Murphy Sean
Insider CIK 1685042 · RDUS Director · NOVN Director · PSTX Director, 10% owner · TLSI Chief Manuf, Strategy&Bus Dev., Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-06-12 | 2025-06-27 | 15,000 | — | $0 | 554,681 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-05-19 | 2025-05-21 | 44,884 | $5.18 | $232.5K | 123,989 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-02-18 | 2025-02-19 | 15,817 | — | $0 | 79,105 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2025-01-28 | 2025-01-29 | 15,000 | $5.17 | $77.5K | 197,732 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-01-27 | 2025-01-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-01-27 | 2025-01-29 | 12,500 | — | $0 | 63,288 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2025-01-27 | 2025-01-29 | 15,000 | $5.31 | $79.7K | 182,732 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2024-02-12 | 2024-02-14 | 105,000 | — | $0 | 105,000 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2024-02-12 | 2024-02-14 | 34,144 | — | $0 | 50,788 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2024-01-24 | 2024-01-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2023-08-11 | 2023-08-14 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RDUS Radius Health, Inc. | D To issuer deriv | 2022-08-15 | 2022-08-15 | 10,000 | $3.60 | $36.0K | 0 | SEC↗ |
| RDUS Radius Health, Inc. | U Tender | 2022-08-15 | 2022-08-15 | 5,500 | $10.00 | $55.0K | 0 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2022-01-14 | 2022-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award | 2022-01-14 | 2022-01-25 | 5,500 | — | $0 | 11,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2021-02-22 | 2021-02-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award | 2021-02-22 | 2021-02-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2020-08-10 | 2020-08-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-15 | 8,746,356 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-15 | 1,457,725 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-15 | 860,585 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-15 | 392,927 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion | 2020-07-14 | 2020-07-15 | 1,168,985 | — | $0 | 8,182,903 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion | 2020-07-14 | 2020-07-15 | 7,013,918 | — | $0 | 7,013,918 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion | 2020-07-14 | 2020-07-15 | 690,124 | — | $0 | 8,873,027 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion | 2020-07-14 | 2020-07-15 | 315,098 | — | $0 | 9,188,125 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | P Buy | 2020-07-14 | 2020-07-15 | 10,000 | $16.00 | $160.0K | 10,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2018-06-04 | 2018-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2017-06-05 | 2017-06-07 | 34,014 | — | $0 | 34,014 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2016-09-20 | 2016-09-22 | 14,484 | — | $0 | 14,484 | SEC↗ |